We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The technology offers an “extended depth-of-focus design to address known optical risk factors associated with myopia progression,” the company said. Read More
The technology “gives clinicians and patients a clinically proven safe and effective alternative to opioids and other drugs for managing this common pain,” the company said. Read More
Self-administered treatment can be delivered through a hand-held unit designed to provide mild electric stimulation through a patient’s skin. Read More
Under the latest reauthorization of MDUFA, the agency only committed to providing complete performance reports on organizations with at least five 510(k) submissions. Read More